Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
- PMID: 1234624
Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
Abstract
The effect of tumor bulk resection on survival was studied in 102 patients with stages II and III ovarian cancer. A multiple linear regression equation provuded both simultenaous control of multiple confounding variables and an assessment of these variables as independent predictors of survival. The most important factors were the histologic grade of the tumor and the size of the largest residual tumor mass after operation. Survival time was uniformly poor if the diameter of the largest residual tumor mass exceeded 1.5 cm irrespective of total tumor volume (mean=12.7 months, SE=1.6 mo). Survival time was inversely proportional to residual mass size under 1.6 cm, and surgery improved survival relative to reduction in mass size below this limit. Extensive resections of tumor bulk with failure to remove all masses greater than 1.5 cm in diameter did not influence survival. Surgery provides optimum benefit when all gross tumor can be excised safely.
Similar articles
-
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.Am J Obstet Gynecol. 1994 Apr;170(4):974-9; discussion 979-80. doi: 10.1016/s0002-9378(94)70090-7. Am J Obstet Gynecol. 1994. PMID: 8166218 Clinical Trial.
-
Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.Cancer. 1992 Oct 15;70(8):2129-36. doi: 10.1002/1097-0142(19921015)70:8<2129::aid-cncr2820700820>3.0.co;2-u. Cancer. 1992. PMID: 1394042
-
Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.Cancer. 1988 Jun 15;61(12):2571-7. doi: 10.1002/1097-0142(19880615)61:12<2571::aid-cncr2820611231>3.0.co;2-o. Cancer. 1988. PMID: 3365677
-
[Surgery in ovarian carcinoma].Gan To Kagaku Ryoho. 1995 Aug;22(9):1176-81. Gan To Kagaku Ryoho. 1995. PMID: 7661569 Review. Japanese.
-
Epithelial ovarian carcinoma: principles of primary surgery.Gynecol Oncol. 1994 Dec;55(3 Pt 2):S91-6. doi: 10.1006/gyno.1994.1346. Gynecol Oncol. 1994. PMID: 7835815 Review.
Cited by
-
Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.World J Surg Oncol. 2015 Aug 5;13:235. doi: 10.1186/s12957-015-0652-0. World J Surg Oncol. 2015. PMID: 26243426 Free PMC article.
-
[Surgical therapy of ovarian cancer].Arch Gynecol Obstet. 1987;242(1-4):26-35. doi: 10.1007/BF01783014. Arch Gynecol Obstet. 1987. PMID: 3688953 German. No abstract available.
-
Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis.Front Oncol. 2024 Jan 18;14:1335883. doi: 10.3389/fonc.2024.1335883. eCollection 2024. Front Oncol. 2024. PMID: 38304874 Free PMC article.
-
Complications of gynaecological cancer surgery: a review.J R Soc Med. 1986 May;79(5):289-93. doi: 10.1177/014107688607900509. J R Soc Med. 1986. PMID: 3522905 Free PMC article. Review. No abstract available.
-
The role of interval debulking surgery in ovarian cancer.Curr Oncol Rep. 2003 Nov;5(6):473-81. doi: 10.1007/s11912-003-0008-8. Curr Oncol Rep. 2003. PMID: 14521806 Review.